Substituted pyrimidine compounds and their use as SYK inhibitors
US9212178B2 · kind B2 · utility
0Cited by
3References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 21, 2014 |
| Grant date | Dec 15, 2015 |
| Priority date | — |
| Expiry date | Oct 21, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of Formula (I) and methods for inhibiting kinases, including spleen tyrosine kinases, are disclosed. Also disclosed are methods for treating a kinase-mediated disease or condition by administering to a subject a therapeutically effective amount of the compound of Formula (I).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.